UiPath (NASDAQ:PATH)‘s stock had its “hold” rating restated by analysts at Canaccord Genuity in a research note issued to investors on Wednesday, The Fly reports. They presently have a $75.00 price target on the healthcare company’s stock, up from their prior price target of $70.00. Canaccord Genuity’s price objective indicates a potential upside of 1.31% from the stock’s current price. The analysts noted that the move was a valuation call.
Other analysts also recently issued reports about the stock. Barclays increased their price target on shares of UiPath from $71.00 to $73.00 and gave the company an “equal weight” rating in a research report on Wednesday. Macquarie began coverage on shares of UiPath in a research report on Monday, May 17th. They issued a “neutral” rating and a $69.00 price target on the stock. Cowen assumed coverage on shares of UiPath in a research report on Monday, May 17th. They issued an “outperform” rating and a $82.00 price target on the stock. Bank of America assumed coverage on UiPath in a research note on Monday, May 17th. They set a “buy” rating and a $85.00 target price for the company. Finally, DA Davidson assumed coverage on UiPath in a research note on Monday, May 17th. They set a “buy” rating and a $85.00 target price for the company. Eleven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $76.89.
Shares of NASDAQ:PATH opened at $74.03 on Wednesday. The company has a 50 day moving average price of $56.76. UiPath has a fifty-two week low of $61.50 and a fifty-two week high of $90.00.
In related news, CEO Daniel Dines sold 1,383,168 shares of the firm’s stock in a transaction on Friday, April 23rd. The shares were sold at an average price of $56.00, for a total value of $77,457,408.00. Also, major shareholder East Fund 2013 Sca Sic Digital sold 2,100,400 shares of the firm’s stock in a transaction on Friday, April 23rd. The shares were sold at an average price of $56.00, for a total transaction of $117,622,400.00. Insiders have sold a total of 5,011,241 shares of company stock valued at $280,629,496 over the last ninety days.
UiPath Company Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. It develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities, such as robust debugging tools, application programming interface automation, wizards to automate desktop or web applications, leverage custom code, and to integrate machine learning models into production workflows.
Featured Story: How can investors find ex-dividend dates?
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.